Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer s Q2 Revenues Inch Up 3 Percent as Income Surges 39 Percent

NEW YORK, July 27 (GenomeWeb News) - PerkinElmer yesterday reported slightly increased revenues and a boost in earnings for the second quarter of 2005.


Revenues for the quarter totaled $425.5 million, representing a 3-percent increase over last year's revenues of $412.1 million during the same period. PE's life and analytical sciences unit had $270.8 million in revenues, up 5 percent from revenues of $257.9 million during the same period last year. This growth was primarily driven by PE's genetic screening, service, and environmental businesses.


Research and development expenses were $22.9 million, up slightly from $21.5 million during the same quarter last year.


The company's net income for the quarter was $28.9 million, or $.22 per share, up from last year's $20.8 million, or $.16 per share, during the same period. This quarter's earnings included both a $14.3 million benefit from provisions for income taxes and a loss of $5.2 million from discontinued operations.


As of July 3, PerkinElmer had $158.7 million in cash and cash equivalents.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.